Document G5m55BDLxdBdJ7wD6MDE7ZxY
SFeronmt:
To: Subject:
I 8 une 2-- 024 105
I ECHA Restriction PEAS;
IEEE
For the ATD (maybe) Visit Or. JN IED, May 14-17
Hi all,
I meeting with Dr J
took place on 15 May.
I There wasorneo oafgeinntdearefsto.r the meeting but according to the first message below, PFAS is oneof[li]
Below the whole exchange of emails for the organisation of this meeting with US Embassy. I don't know if this exchange should be added to the ATD documents or not.
Kind regards,
Sreonmt;:IMonday, May 6 2024 11:46 AM5
TSou:bjoct: RE: Vist Or
Vy 16.J1e7cha.europa.cu>
Hieno jut, monet kitokset,IsNEaksi voit imoitasINN invtV,esa
EPmhaoinle os ov Organization Te mole Us. EmbasasytHeelsoinvki fcailce
:
a fr -i
_
ay 1647
ei 1 shen (15.5) Kio 13:30-14:30.
|alkaa sitten seuraava kokous klo 14:30.
Feria pacissaan ti Tokere. Tuto MMIkana muta?
Tarvitsisin kaikkien tulijoiden nimet (meidn security - reception kollegoille) niin kuin ne on kirjoittettu
st.terv.J
-- rom:I ---------:>
TSo: NeE
[echa.curopa.cu>
vel aPalmaiisinnvieelltouopheon3m3ahhdvoilmliessmenmkeaskiCviihkoan ttapaSa0m5i0s,eeon,ttisall smpyisttalieka.taulut vielselavt.Jilin edelinen Eg
To]Sent: Friday, May 3, 2024 10:40 AeMso
Such RE vr
er 017
.
Dear I IE
Please be informed thaJt IlIES
hour meeting.
welcomes to meJleBEtN at ECHA, and suggests a one-
We hope that one of the following times would be suitableforJillIEE
~ On 14" May anytime between 11:00 and 15:00, or
- On 15" May 11:00-12:00
Regarding practicalities, you can find information about the access to our premises in the "Guide for
visitors" on our website: 2faf6414-f868-65fd-1f6b-0237c70670c4 (europa.eu)
Kind regards, -.
I
Directorate of Risk Management
.=
echa.curopa.eu
`P.e0c.haB.eouxro4p0a0.,euF1-00121 Helsinki Finland
77 EMAS Registered 2 11500 0H0o0n1i::2200115scceonttised
E HA EUROPEAN CHEMICALS AGENCY
XI [=]in}
TChhhoeerrmatcbao1vs3eaAdgreeenspctryae:sde,TnhtiIssyetohmuetv,oepiiin8occnueiaogfdatn1hyeSlmaeusethtsoarcahaeni ddetriso,i,noeitsanasennndofaofidbcifaotlrtheptoshtuosren aofoftohoethnme2dEipudoruospnseea0.n and dee the message
TSaent: Thursday, May 2, 2024 138 PM
oSufbject: Vist Or)
echa,.Meauyro1o0n-s1u7>
echs.ouropa.eu>
oeJ r
`Thank you very much for your colldaurbingo[JrE aNtEiNovnisi to Finland.
The Embassy will be hosting National Science Foundation scieJntiNsEtE, the weok of May 13.Jl is aternatives. 5 building a transatlantic network for sustainable semiconductor manufacture, focusing on developing PFAS
J vould appreciate an opportunity tovisit ECHA. Please let me know if you hav any availabilty for the week of
May 13 (ideally May 14 or 15). We are happy to host you at the Embassy or meet you wherever is most convenient.
With ind rogarcs,J
tos /unsgou/stafstaft bio sp?lancimolnarBiorg=NSF&from org=
Biography:
or.JIN = scientist and entrepreneur with more than 20 years of experience in the fe science and
chemical industries, integratingJf] scientific research and enginring background with commercialzation for
startups, and international government, and business environments. CurrentJly, i+ IS
or the
NSF Convergence Accelerator Program in the new Technology, Innovations, and Partnerships (TIP) Directorate at the
Uo.rSg.anNiaztaitoinoanlalScsitreunccteuFreouannddataictoinvi(tNySwF)i.thTihnetChoenNvSeFr,gdeensciegnAecdcetloeraactcoerleirsaateretlhateitverlaynsniteiwon(olfauunsceh-eidnsipnir2e0d19) convergence research nto practice in areas of national importaAgnuicdein.g rationle of the Convergence Accelerator is that to achieveprogress on scientific and societal challenges it is necessary to develop teams that can share expertise across research fields as well aswith multiple partners and stakeholders, including the ultimate Duisveirssioonf otfheInrdeussetrairaclhIpnrnoodvuacttsi.onPraenvidouPsalryt,naJrslhi]pswahesreP[rJofg]rmaamnDaigreecdtoarpion rthteolNSoiFfcEPnhgaisneee|rainndg PDihraescetoIIraStBeIRin/StThTeR grants. J] alo served on the Working Groforuthpe NSF Emerging Frontiers in Research and Innovation program (EFRI), which provides citca, strategic support of fundamental discovery at the frontiers of engineering research and education.
prior to joining NF,Jl] wasco-founder and CEOof Smpatica Medicine, Inc, an atfical intelligence precision medicine company based in San Francisco, Caifornia. [Jl founded and advised numerous fe science startup companies from top universities. [Jf has aso provided strategic consultancy to venture capital firms, public Dciormepcatnoireisn,tnhoen-LipfreofSictieinncsetistuMteers,chaanndtthBeanfkeidnerggarl oguovperannmdenVte.ntu[rJel GbraocukpgratouBnurdriilnlc&luCdeosmppoasniyt,ionEsxeacsutMiavneaigning Residence at Momentum Biosciences, Program Officerforthe National Cancer Insitute in the Officeof the Director (NCAeSnAteArmfeorsSRtreasteeagricchScCieenntteifri,caInnidtiRatoihvems),&aHnadssreCsoe.ar[cJh la]ndcobmupsilneetsesddtehveeUlnoipvmeersnittyroolfesPaetnCnsayllivpaenriaL'ise WShciaerntcoesn,
Executive Management Program and holds a Ph.D. from the Program in PolymerScience and Technology (Materials
SfcrioemncteheanUndivCehresmiitcyaolfEPnigtitnsebeurrignhg()mfargonmaMcaussmaclahuudse)e,tts Instituteof Technology and a B.S. in Chemistry (Biology)
U.S. Embassy, Helsinki
Moty
Tet
emai:
soy
4